Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4450663 | 0.75 | — | — | |
| SCHEMBL9639817 | 0.75 | — | — | |
| SCHEMBL15598 | 0.73 | — | — | |
| SCHEMBL22770085 | 0.73 | — | — | |
| SCHEMBL7522298 | 0.73 | EGFR (0.38) | EGFRKDM4ECISD1SLC16A3ALDH1A1 | |
| SCHEMBL11219397 | 0.73 | — | — | |
| SCHEMBL110533 | 0.73 | — | — | |
| SCHEMBL15597 | 0.73 | — | — | |
| SCHEMBL18315247 | 0.73 | — | — | |
| SCHEMBL10885668 | 0.71 | EGFR (0.37) | EGFRKDM4ECISD1SLC16A3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9752049-B2 | Optically transparent, superhydrophobic, biocompatible thin film coatings and methods for producing same | UT-BATTELLE, LLC (US) | 2017-09-05 | — | — | US | claimed |
| US-20150232690-A1 | OPTICALLY TRANSPARENT, SUPERHYDROPHOBIC, BIOCOMPATIBLE THIN FILM COATINGS AND METHODS FOR PRODUCING SAME | UT-BATTELLE, LLC (US) | 2015-08-20 | — | — | US | claimed |
| EP-1360257-B1 | CYANOACRYLATE COMPOSITIONS CURABLE TO FLEXIBLE POLYMERIC MATERIALS | LOCTITE R & D LTD (IE) | 2007-07-25 | — | — | EP | claimed |
| US-6977278-B1 | Cyanoacrylate compositions curable to flexible polymeric materials | LOCTITE (R&D) LTD. (IE) | 2005-12-20 | — | — | US | claimed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | claimed |
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4532465-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023232948-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2023-12-07 | — | — | WO | disclosed |
| EP-4286369-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2023-12-06 | — | — | EP | disclosed |
| EP-3947586-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2022-02-09 | — | — | EP | disclosed |
| US-20220033544-A1 | FLEXIBLE PHOTOCURABLE CYANOACRYLATE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2022-02-03 | — | — | US | disclosed |
| EP-3329846-B1 | COMPOSITION FOR DETECTING LATENT FINGERPRINT | TOAGOSEI CO LTD (JP) | 2021-07-14 | — | — | EP | disclosed |
| US-20040058058-A1 | Prefatory anti-forgery protection and consecutive machine-assisted authentication of genuine documents and other values | SHCHEGOLIKHIN ALEXANDER NIKITO (RU) | 2004-03-25 | — | — | US | disclosed |
| WO-2004024467-A2 | SURFACE-MOUNTING SYSTEM | LOCTITE (R & D) LIMITED (IE) | 2004-03-25 | — | — | WO | disclosed |
| EP-1385637-A1 | IMPROVED RAMAN-ACTIVE TAGGANTS AND THEIR RECOGNITION | Quantag Systems, Inc. (US) | 2004-02-04 | — | — | EP | disclosed |
| US-6610351-B2 | Spectroscopy | QUANTAG SYSTEMS, INC. | 2003-08-26 | — | — | US | disclosed |
| WO-2002085543-A1 | IMPROVED RAMAN-ACTIVE TAGGANTS AND THEIR RECOGNITION | QUANTAG SYSTEMS, INC. (US) | 2002-10-31 | — | — | WO | disclosed |
| US-20020025490-A1 | Spectroscopy | CHROMATIC TECHNOLOGIES, INC. | 2002-02-28 | — | — | US | disclosed |
| US-5248708-A | Adhesive composition consisting primarily of α-cyanoacrylate compound | OHARA PARAGIUM CHEMICAL CO., LTD. (JP) | 1993-09-28 | — | — | US | disclosed |
| US-4764545-A | Process for preparing α-cyanoacrylate type compounds and adhesive composition comprising α-cyanoacrylate type compound obtained by the process as its main component | OHARA PARAGIUM CHEMICAL, CO., LTD. (JP) | 1988-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BAP1, CBR1, CBR3 | EGFR 4175/4885KDM4E 1134/4885CISD1 2339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.